Envestnet Asset Management Inc. trimmed its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 31.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,514 shares of the company's stock after selling 7,220 shares during the period. Envestnet Asset Management Inc.'s holdings in Molina Healthcare were worth $4,515,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of MOH. Versant Capital Management Inc grew its stake in Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. acquired a new stake in Molina Healthcare in the fourth quarter worth about $52,000. Hurley Capital LLC purchased a new stake in shares of Molina Healthcare during the fourth quarter worth about $55,000. EverSource Wealth Advisors LLC increased its holdings in shares of Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after acquiring an additional 88 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its position in shares of Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after purchasing an additional 155 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.
Molina Healthcare Stock Performance
Shares of NYSE MOH opened at $321.20 on Wednesday. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $370.99. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company's fifty day moving average price is $316.43 and its 200 day moving average price is $307.66. The company has a market capitalization of $17.57 billion, a PE ratio of 15.72, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Insider Activity
In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.10% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. Robert W. Baird restated a "neutral" rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Sanford C. Bernstein initiated coverage on Molina Healthcare in a research report on Tuesday. They issued an "outperform" rating and a $414.00 target price on the stock. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. Truist Financial boosted their price target on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Finally, Stephens restated an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a research note on Thursday, February 6th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Molina Healthcare currently has a consensus rating of "Hold" and an average target price of $363.62.
Read Our Latest Stock Analysis on Molina Healthcare
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.